Estimating the impact of a novel drug regimen for treatment of tuberculosis: a modeling analysis of projected patient outcomes and epidemiological considerations

Abstract Background Regimens that could treat both rifampin-resistant (RR) and rifampin-susceptible tuberculosis (TB) while shortening the treatment duration have reached late-stage clinical trials. Decisions about whether and how to implement such regimens will require an understanding of their lik...

Full description

Bibliographic Details
Main Authors: Emily A. Kendall, Shelly Malhotra, Sarah Cook-Scalise, Claudia M. Denkinger, David W. Dowdy
Format: Article
Language:English
Published: BMC 2019-09-01
Series:BMC Infectious Diseases
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12879-019-4429-x